Lamisil Dermgel

Terbinafine, the active ingredient in Lamisil Dermgel, is a allylamine antifungal presented as a gel for topical use. It treats fungal skin infections such as athlete’s foot, ringworm, and nail fungus in both adults and children.

GNH USA supplies Lamisil Dermgel as a licensed, GDP‑compliant international pharmaceutical supplier, meeting stringent EU quality standards and serving hospitals, pharmacies and clinics worldwide through a robust logistics platform that ensures timely, temperature‑controlled delivery and compliance with all applicable regulatory requirements across multiple regions.

Terbinafine is used to treat superficial fungal infections of the skin and nails.

- Tinea pedis: relieves itching and clears fungal infection of the feet. - Tinea corporis: eliminates ring‑shaped lesions on the body. - Tinea cruris: treats fungal infection of the groin area. - Tinea unguium: improves appearance of infected nails. - Ringworm: eradicates dermatophyte infection on skin surfaces.

Topical application of Lamisil Dermgel may be associated with local and, rarely, systemic adverse reactions.

Common Side Effects: - Application site irritation: mild redness or itching at the site. - Burning sensation: transient warmth after application. - Dryness: skin may become dry or flaky. - Pruritus: occasional itching unrelated to infection.

Serious or Rare Side Effects: - Allergic contact dermatitis: severe rash, swelling, or blistering. - Systemic hypersensitivity: urticaria, angioedema, or anaphylactic signs. - Hepatic effects: rare elevation of liver enzymes with extensive use.

Before using Lamisil Dermgel, consider the following precautions to ensure safe and effective therapy.

- Pregnancy: consult a healthcare professional before application. - Breastfeeding: discuss potential risks with a physician. - Age restrictions: safety in children under two years has not been established. - Liver disease: use with caution and monitor hepatic function if extensive skin area is treated. - Concomitant medications: inform the prescriber of all topical or systemic drugs being used. - Store at room temperature: keep the gel in its original container, protect from moisture and direct sunlight.

Lamisil Dermgel may interact with certain systemic and topical agents; awareness of these interactions helps minimize adverse outcomes.

Major Interactions (Avoid): - Systemic antifungals (e.g., itraconazole, fluconazole): may increase systemic terbinafine exposure. - Strong CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can alter terbinafine metabolism. - Alcohol: excessive intake may heighten risk of liver toxicity.

Moderate Interactions (Monitor Closely): - Topical corticosteroids: may mask local irritation or infection signs. - Other topical agents (e.g., salicylic acid): may increase skin irritation. - Warfarin: extensive application may affect INR, requiring monitoring.